PIOGLITAZONE INOVAMED 45

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

PIOGLITAZONE AS HYDROCHLORIDE

متاح من:

INOVAMED LTD

ATC رمز:

A10BG03

الشكل الصيدلاني:

TABLETS

تركيب:

PIOGLITAZONE AS HYDROCHLORIDE 45 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

AUROBINDO PHARMA LTD., INDIA

المجال العلاجي:

PIOGLITAZONE

الخصائص العلاجية:

Pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below: as monotherapy - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with- metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin- a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.- Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance .

تاريخ الترخيص:

2021-06-20

نشرة المعلومات

PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS )PREPARATIONS( – 1986
The medicine is dispensed with a doctor’s prescription only
Name of the medicine, its form and strength
PIOGLITAZONE INOVAMED 15
TABLETS
PIOGLITAZONE INOVAMED 30
TABLETS
PIOGLITAZONE INOVAMED 45
TABLETS
Each Pioglitazone Inovamed 15 tablet contains:
Pioglitazone hydrochloride 15 mg
Each Pioglitazone Inovamed 30 tablet contains:
Pioglitazone hydrochloride 30 mg
Each Pioglitazone Inovamed 45 tablet contains:
Pioglitazone hydrochloride 45 mg
For the list of inactive and allergenic ingredients in the
preparation,
see “Further Information” in section 6. See also “Important
information
about some of the ingredients of the medicine” in section 2 of this
leaflet.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE
MEDICINE.
This leaflet contains concise information about the medicine. If you
have further questions, refer to the doctor or pharmacist.
This medicine has been prescribed for the treatment of your ailment.
Do not pass it on to others. It may harm them, even if it seems to
you that their medical condition is similar.
The medicine is not intended for children and adolescents below
the age of 18 years.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for the treatment of type 2 diabetes
)non-insulin dependent( in patients whose blood sugar level cannot
be controlled by treatment with metformin alone.
Pioglitazone Inovamed is given as monotherapy in patients who are
unable to take metformin and whose blood sugar level cannot be
controlled by diet or exercise. Pioglitazone Inovamed is also given
in combination with other medicines for the treatment of diabetes
)such as metformin, sulphonylurea or insulin( when adequate
control of blood sugar level has not been achieved.
Pioglitazone Inovamed helps control the blood sugar level by
improving the response of the body’s cells to insulin produced in
the body.
THERAPEUTIC GROUP:
The medicine belongs to the thiazolidinedione group for the
trea